IP Forecast: Novartis To Fight Antitrust Row Over Drug Patent

By Andrew Karpan · October 5, 2023, 9:38 PM EDT

Novartis is set to oppose an appeal at the Second Circuit from a rival seeking to restore an antitrust suit accusing it of hiding things from the patent office to illegally...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Regeneron Pharmaceuticals, Inc v. Novartis Pharma AG

Case Number

22-427

Court

Appellate - 2nd Circuit

Nature of Suit

3410 STATUTES-Antitrust

Date Filed

March 01, 2022